| Typicality: | 0.380 |
| Saliency: | 0.501 |
| in early studies | 13 | location |
| in early trials | 11 | temporal |
| in phase | 9 | temporal |
| drug → shown → promise | 76 |
| drug → be shown → promise | 19 |
| drug → shown → great promise | 6 |
| drug → show → significant promise | 6 |
| drug → shown → some promise | 5 |
| drug → shown → the most promise | 4 |
| drug → shown → early promise | 4 |
| drug → shown → a lot of promise | 3 |
| drug → shown → such promise | 3 |
| drug → shown → great deal of promise | 3 |
| negative | neutral | positive |
| 0.088 | 0.246 | 0.667 |
| Raw frequency | 129 |
| Normalized frequency | 0.501 |
| Modifier score | 0.510 |
| Perplexity | 39.190 |